as on March 11, 2026 at 6:59 am IST
Day's Low
Day's High
1.91%
Downside
1.13%
Upside
52 Week's Low
52 Week's High
14.63%
Downside
249.51%
Upside
Check Corcept Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.6B
EPS (TTM)
0.384
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.22%
PE Ratio (TTM)
41.45
Industry PE ratio
7.871681415929204
PEG Ratio
0.813
EBITDA
45.9M
Revenue (TTM)
761.4M
Profit Margin
13.09%
Return On Equity TTM
15.02%
Track how Corcept Therapeutics Inc P/E has moved over time to understand its valuation trends.
Corcept Therapeutics Inc in the last 5 years
Lowest (22.29x)
March 31, 2024
Industry (7.87x)
March 10, 2026
Today (41.45x)
March 10, 2026
Highest (95.87x)
December 31, 2025
Today’s Price to Earnings Ratio: 41.45x
Compare market cap, revenue, PE, and other key metrics of Corcept Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.6B | 37.28% | 41.45 | 13.09% | |
| BUY | $42.5B | 140.27% | 137.03 | 8.45% | |
| BUY | $116.0B | 115.07% | 29.85 | 32.94% | |
| NA | $33.3B | NA | 590.43 | 5.37% | |
| BUY | $80.3B | 67.03% | 18.31 | 31.41% |
The Corcept Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Corcept Therapeutics Inc investment value today
Current value as on today
₹64,714
Returns
Returns from Corcept Therapeutics Inc Stock
Dollar Returns*
₹5,192 (+5.19%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Corcept Therapeutics Inc. Average target price of $65.4
Get share price movements and forecasts by analysts on Corcept Therapeutics Inc.
What analysts predicted
48.67%UPSIDE
Target Price
$65.4
Current Price
$33.57
Analyzed by
11 Analysts
Target
$65.40
Corcept Therapeutics Inc target price $65.4, a slight upside of 48.67% compared to current price of $33.57. According to 11 analysts rating.
Investment in Corcept Therapeutics Inc Shares on INDmoney has dropped by -43.56% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Corcept Therapeutics Inc Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 19.35M → 24.28M (in $), with an average increase of 20.3% per quarter
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 38.8% return, outperforming this stock by 78.5%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.2% return, outperforming this stock by 13.0%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 207.63M → 202.12M (in $), with an average decrease of 2.7% per quarter
Price Dip
![]()
In the last 3 months, CORT stock has moved down by -60.2%
| Organisation | Corcept Therapeutics Inc |
| Headquarters | 101 Redwood Shores Parkway, Redwood City, CA, United States, 94065 |
| Industry | Health Technology |
| CEO | Dr. Joseph K. Belanoff M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Roberto W. Vieira | President of Oncology |
Dr. Joseph K. Belanoff M.D. | Co-Founder, President, CEO & Director |
Mr. Atabak Mokari | CFO & Treasurer |
Ms. Monica Tellado | President of Emerging Markets |
Mr. Joseph Douglas Lyon | Chief Technology & Accounting Officer |
Dr. Hazel Hunt Ph.D. | Chief Scientific Officer |
Ms. Amy Flood | Chief Human Resources & Communications Officer |
Mr. Sean Maduck | President of Endocrinology |
Dr. William Guyer Pharm.D. | Chief Development Officer |
Mr. Gary Charles Robb J.D. | Chief Business Officer & Secretary |
Corcept Therapeutics Inc share price today is $33.57 as on . Corcept Therapeutics Inc share today touched a day high of $33.95 and a low of $32.93.
Corcept Therapeutics Inc share touched a 52 week high of $117.33 on and a 52 week low of $28.66 on . Corcept Therapeutics Inc stock price today i.e. is trending at $33.57,which is 71.39% down from its 52 week high and 17.13% up from its 52 week low.
Corcept Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Corcept Therapeutics Inc (CORT) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Corcept Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Corcept Therapeutics Inc share’s latest price of $33.57 as on March 11, 2026 at 1:29 am IST, you will get 0.2979 shares of Corcept Therapeutics Inc. Learn more about
fractional shares .
Corcept Therapeutics Inc stock has given 37.28% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?